ICPT NASDAQ
Intercept Pharmaceuticals, Inc.
1W: +0.0%
1M: +1.8%
3M: +89.6%
1Y: +17.9%
3Y: -51.6%
5Y: -82.5%
$19.00
Last traded 2023-11-14 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
📊 Key Metrics
TTM$318M
Revenue
-3.8% YoY
$-59M
Net Income
-152.1% YoY
$-63M
Free Cash Flow
-230.9% YoY
99.8%
Gross Margin
-5.2%
Op. Margin
-3.1%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-65.3%
ROA-12.3%
ROIC182.1%
Valuation
P/E5.6
P/B6.9
EV/EBITDA-19.3
Leverage
Debt/Equity3.12
Current Ratio4.22
Interest Cov.-16.6x
Quality Scores
Piotroski F4/9
Altman Z-6.00
Beneish M-2.35